Glucose-Dependent Insulinotropic Polypeptide Stimulation of Lipolysis in Differentiated 3T3-L1 Cells: Wortmannin-Sensitive Inhibition by Insulin**This work was supported by grants from Zymogenetics Inc. (Seattle, WA), the Medical Research Council of Canada (5–90007-RAP/CHSM) and the Canadian Diabetes Association (CHSM/RAP).
The DOI matches its Crossref record; 46 of the 49 references it cites were found in a registry or an index.
Abstract
GIP is an important insulinotropic hormone (incretin) that has also been implicated in fat metabolism. There is controversy regarding the actions of GIP on adipocytes. In the current study, the existence of GIP receptors and effects of GIP on lipolysis were studied in differentiated 3T3-L1 cells. GIP receptor messenger RNA was detected by RT-PCR and RNase protection assay. Receptors were detected in binding studies (IC50 26.7 +/- 0.7 nM). GIP stimulated glycerol release with an EC50 of 3.28 +/- 0.63 nM. GIP (10(-9)-10(-7) M) +/- IBMX increased cAMP production by 1180-2246%. The adenylyl cyclase inhibitor MDL 12330A (10(-4) M) inhibited GIP-induced glycerol production by >90%, and reduced cAMP responses to basal. Preincubation of 3T3-L1 cells with insulin inhibited glycerol responses to GIP, and the inhibitory effect of insulin was blocked by the phosphatidylinositol 3'-kinase inhibitor, wortmannin. It is concluded that GIP stimulates glycerol release in 3T3-L1 cells primarily via stimulation of cAMP production, and that insulin antagonizes GIP-induced lipolysis in a wortmannin-sensitive fashion. It is suggested that effects of GIP on fat metabolism in vivo may depend upon the circulating insulin level, and that meal-released GIP may elevate circulating fatty acids, thus optimizing pancreatic beta-cell responsiveness to stimulation by glucose and GIP.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“GIP promotes lipogenesis and lipid deposition under conditions of hyperinsulinema [34–36] while stimulating lipolysis and fatty acid oxidation under conditions of normo- or hypoinsulinemia [37–39].”
From Dual and Triple Incretin-Based Co-agonists: Novel Therapeutics for Obesity and Diabetes (2024) · cites this paper as [38]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426 · cited 1×
“Total RNA was isolated from 3T3-L1 cells (passage 7) or rat epididymal fat using a modification of the method of Chomczynski and Sacchi (22) (Trizol; Gibco BRL, Life Technologies, Burlington, Ontario, Canada).”
MethodSignalling through the lipid products of phosphoinositide-3-OH kinase
Toker, A., & Cantley, L. C. (1997) · Nature · doi:10.1038/42648 · Cited by 1,304 · cited 7×
“However, PI-3-kinase involvement in the antilipolytic action of insulin is well established (43, 44), and it seems likely that this enzyme is involved in insulin’s effect on GIP-stimulated lipolysis.”
BackgroundInfluentialOkada, T., Kawano, Y., Sakakibara, T., Hazeki, O., & Ui, M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41901-6 · Cited by 918 · cited 1×
“of insulin is well established (43, 44), and it seems likely that”
BackgroundThe insulin signalling system and the IRS proteins
White, M. F. (1997) · Diabetologia · doi:10.1007/s001250051387 · Cited by 581
Peptides and Protein Phosphorylation
Kemp, B. E. (2018) · CRC Press eBooks · doi:10.1201/9781351075442 · Cited by 514
Structure, Localization, and Regulation of cGMP-inhibited Phosphodiesterase (PDE3)
Degerman, E., Belfrage, P., & Manganiello, V. C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.11.6823 · Cited by 428 · cited 1×
“Insulin’s suppressive effect on catecholamine-induced lipolysis has been shown to involve activation of cAMP phosphodiesterase (27, 35), resulting in reduced cAMP levels, and dephosphorylation of hormone-sensitive lipase via activation of a protein phosphatase (36).”
BackgroundEssentiality of circulating fatty acids for glucose-stimulated insulin secretion in the fasted rat.
Stein, D. T., Esser, V, Stevenson, B. E., Lane, K. E., Whiteside, J. H., Daniels, M. B., Chen, S., & McGarry, J. D. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118727 · Cited by 378
Regulation of ob gene mRNA levels in cultured adipocytes
Rentsch, J., & Chiesi, M. (1996) · FEBS Letters · doi:10.1016/0014-5793(95)01485-3 · Cited by 259 · cited 1×
“Cells were induced to differentiate into the adipocyte phenotype by a modification of the method described by Rentsch and Chiesi (21).”
MethodLam, K., Carpenter, C. L., Ruderman, N. B., Friel, J. C., & Kelly, K. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32042-2 · Cited by 232
Gastric Inhibitory Polypeptide Enhanced Lipoprotein Lipase Activity in Cultured Preadipocytes
Eckel, R. H., Fujimoto, W. Y., & Brunzell, J. D. (1979) · Diabetes · doi:10.2337/diab.28.12.1141 · Cited by 219 · cited 1×
“GIP has also been shown to stimulate lipoprotein lipase activity in cultured preadipocytes (13), an effect that would result in increased cellular uptake of triglycerides.”
BackgroundHormone-sensitive lipase — A multipurpose enzyme in lipid metabolism
Yeaman, S. J. (1990) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(90)90067-n · Cited by 215 · cited 1×
“of hormone-sensitive lipase activity (19), it would be an-”
BackgroundHandbook of Physiology, Section 6: The Gastrointestinal System
Greenberger, N. J. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03500160119051 · Cited by 211
Gastric Inhibitory Polypeptide
Brown, J. C. (1982) · Monographs on endocrinology · doi:10.1007/978-3-642-81771-7 · Cited by 171
Effect of gastric inhibitory polypeptide on plasma levels of chylomicron triglycerides in dogs.
Wasada, T., McCorkle, K., Harris, V, Kawai, K., Howard, B., & Unger, R. H. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110335 · Cited by 153 · cited 1×
“Administration of GIP promoted chylomicron-associated triglyceride clearance from blood in dogs (11), and reduced peak plasma triglyceride levels during an intraduodenal fat infusion in rats (12).”
BackgroundSTRÅLFORS, P., & HONNOR, R. C. (1989) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1989.tb14842.x · Cited by 150 · cited 1×
“Insulin’s suppressive effect on catecholamine-induced lipolysis has been shown to involve activation of cAMP phosphodiesterase (27, 35), resulting in reduced cAMP levels, and dephosphorylation of hormone-sensitive lipase via activation of a protein phosphatase (36).”
BackgroundGlucose-fatty acid interactions in health and disease
Jd, M. (1998) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/67.3.500s · Cited by 148 · cited 1×
“In addition to its effect on insulin secretion, GIP has also been implicated in the regulation of fat metabolism, an action that could also be of paramount importance in the normal regulation of insulin secretion (5).”
BackgroundGutniak, M. K., Linde, B., Holst, J. J., & Efendić, S. (1994) · Diabetes Care · doi:10.2337/diacare.17.9.1039 · Cited by 139 · cited 1×
“This incretin action is shared by peptide products of the proglucagon gene, glucagon-like peptide-1 (GLP-1(7– 36amide)) and GLP-1(7–37) (3), and there is currently considerable interest in the potential of using incretin analogs for the treatment of noninsulin-dependent diabetes mellitus (NIDDM) (4).”
BackgroundEbert, R., & Creutzfeldt, W. (1980) · Diabetologia · doi:10.1007/bf00275269 · Cited by 138
Wheeler, M. B., Gelling, R. W., McIntosh, C. H., Georgiou, J., Brown, J. C., & Pederson, R. A. (1995) · Endocrinology · doi:10.1210/endo.136.10.7664683 · Cited by 130 · cited 5×
“Synthetic porcine GIP (5 mg) was iodinated by the chloramine-T method, and the (125)I-GIP further purified by reverse phase HPLC to a specific activity of 250–350 mCi/mg (17).”
BackgroundMethodInfluentialSelf-citationThe β-Adrenergic Receptor Is a Substrate for the Insulin Receptor Tyrosine Kinase
Baltensperger, K., Karoor, V., Paul, H., Ruoho, A., Czech, M. P., & Malbon, C. C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.2.1061 · Cited by 99
Effects of gastric inhibitory polypeptide on glucose and lipid metabolism of isolated rat adipocytes
Hauner, H., Glatting, G., Kaminska, D., & Pfeiffer, E. F. (1988) · Annals of Nutrition and Metabolism · doi:10.1159/000177467 · Cited by 98 · cited 1×
“incorporation of both fatty acids (10) and glucose (14) into”
BackgroundMontrose‐Rafizadeh, C., Yang, H. M., Wang, Y., Roth, J., Montrose, M. H., & Adams, L. G. (1997) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199709)172:3<275::aid-jcp1>3.0.co;2-l · Cited by 94 · cited 2×
“Recently, GLP-1 (7–36) was described as having insulin-like effects in 3T3-L1 cells, reducing cAMP production (29), and increasing glucose uptake and expression of the glucose transporters GLUT1 and GLUT4 (30), whereas GIP was without effect.”
BackgroundThe Incretin Notion and its Relevance to Diabetes
Habener, J. F. (1993) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30135-x · Cited by 89 · cited 1×
“This incretin action is shared by peptide products of the proglucagon gene, glucagon-like peptide-1 (GLP-1(7– 36amide)) and GLP-1(7–37) (3), and there is currently considerable interest in the potential of using incretin analogs for the treatment of noninsulin-dependent diabetes mellitus (NIDDM) (4).”
BackgroundGastric inhibitory polypeptide (GIP)
O’Dorisio, T. M., Cataland, S., Stevenson, M., & Mazzaferri, E. L. (1976) · Digestive Diseases and Sciences · doi:10.1007/bf01073027 · Cited by 88
Kawamura, M., Jensen, D. F., Wancewicz, E. V., Joy, L. L., Khoo, J. C., & Steinberg, D. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.2.732 · Cited by 85 · cited 1×
“Differentiation of 3T3-L1 preadipocytes is accompanied by increases in proteins characteristic of mature adipocytes including catecholamine-stimulated adenylyl cyclase (25), hormone-sensitive lipase (26), and cAMP phosphodiesterase (27).”
BackgroundLai, E. K., Rosen, O. M., & Rubin, C. S. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42976-6 · Cited by 82 · cited 1×
“Differentiation of 3T3-L1 preadipocytes is accompanied by increases in proteins characteristic of mature adipocytes including catecholamine-stimulated adenylyl cyclase (25), hormone-sensitive lipase (26), and cAMP phosphodiesterase (27).”
BackgroundEbert, R., Nauck, M., & Creutzfeldt, W. (1991) · Hormone and Metabolic Research · doi:10.1055/s-2007-1003745 · Cited by 79 · cited 1×
“Administration of GIP promoted chylomicron-associated triglyceride clearance from blood in dogs (11), and reduced peak plasma triglyceride levels during an intraduodenal fat infusion in rats (12).”
BackgroundKaroor, V., Baltensperger, K., Paul, H., Czech, M. P., & Malbon, C. C. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.43.25305 · Cited by 72 · cited 1×
“Additionally, insulinreceptor interaction has been shown to result in phosphorylation of tyrosine residues in G protein-coupled receptors, including the b2-adrenergic receptor, an effect that is believed to be directly mediated by the intrinsic tyrosine kinase activity of the insulin receptor (37, 38).”
BackgroundElks, M. L., Manganiello, V. C., & Vaughan, M. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)32095-7 · Cited by 71 · cited 2×
“Differentiation of 3T3-L1 preadipocytes is accompanied by increases in proteins characteristic of mature adipocytes including catecholamine-stimulated adenylyl cyclase (25), hormone-sensitive lipase (26), and cAMP phosphodiesterase (27).”
BackgroundRecent Studies of the 3T3-L1 Adipocyte-Like Cell Line
Rosen, O. M., Smith, C. J., Hirsch, A. H., Lai, E. K., & Rubin, C. S. (1979) · Elsevier eBooks · doi:10.1016/b978-0-12-571135-7.50015-1 · Cited by 65 · cited 2×
“agreement with earlier studies (20, 28), and GIP effects could not, therefore, have been mediated via the glucagon receptor.”
BackgroundResultHirsch, A. H., & Rosen, O. M. (1984) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37755-5 · Cited by 55
Wang, Y., Kole, H., Montrose-Rafizadeh, C., Perfetti, R., Bernier, M., & Egan, J. (1997) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0190241 · Cited by 54 · cited 1×
“Recently, GLP-1 (7–36) was described as having insulin-like effects in 3T3-L1 cells, reducing cAMP production (29), and increasing glucose uptake and expression of the glucose transporters GLUT1 and GLUT4 (30), whereas GIP was without effect.”
BackgroundInhibition of actions of glucagon in adipocytes by gastric inhibitory polypeptide
Dupre, J., Greenidge, N., McDonald, T. J., Ross, S. A., & Rubinstein, D. (1976) · Metabolism · doi:10.1016/s0026-0495(76)80002-9 · Cited by 53 · cited 2×
“Both groups reported that GIP displaced (125)I-glucagon binding from adipocytes, implying that GIP interacted with the glucagon receptor (15, 16).”
BackgroundGastric inhibitory polypeptide: a gut hormone with anabolic functions
Beck, B. (1989) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0020169 · Cited by 53 · cited 2×
“incorporation of both fatty acids (10) and glucose (14) into”
BackgroundGelling, R. W. (1997) · Endocrinology · doi:10.1210/en.138.6.2640 · Cited by 51 · cited 1×
“The 3T3-L1 adipocytes express a GIP receptor with similar characteristics to that from the rat pancreatic islet (17, 18) although it appears that, under the conditions of culture used, the receptor population is mainly in a lower affinity state.”
BackgroundSelf-citationKubota, A., Yamada, Y., Yasuda, K., Someya, Y., Ihara, Y., Kagimoto, S., Watanabe, R., Kuroe, A., Ishida, H., & Seino, Y. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6743 · Cited by 50
The importance of triglyceride hydrolysis for the release of gastric inhibitory polypeptide
Ross, S. A., & Shaffer, E. A. (1981) · Gastroenterology · doi:10.1016/0016-5085(81)90199-2 · Cited by 48
Gastric Inhibitory Polypeptide
Brown, J. C., Buchan, A. M. J., McIntosh, C. H. S., & Pederson, R. A. (1989) · Comprehensive Physiology · doi:10.1002/cphy.cp060218 · Cited by 46
Self-citationEvans, J. L., Honer, C. M., Womelsdorf, B. E., Kaplan, E. L., & Bell, P. A. (1995) · Cellular Signalling · doi:10.1016/0898-6568(95)00007-c · Cited by 43 · cited 1×
“of insulin is well established (43, 44), and it seems likely that”
BackgroundStraub, S. G., & Sharp, G. W. G. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1035 · Cited by 36 · cited 1×
“GIP-stimulated insulin secretion from HIT cells (41) and GIP-”
BackgroundGrupp, G., Grupp, I. L., Johnson, C. L., Matlib, M. A., ROUSLIN, W., Schwartz, A., Wallick, E. T., Wang, T., & Wisler, P. L. (1980) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1980.tb08721.x · Cited by 31 · cited 2×
“The concentration required to inhibit adenylyl cyclase is similar to that previously shown to be necessary in heart cells (31).”
BackgroundResultGIP receptors and signal‐transduction mechanisms
McIntosh, C. H. S., Wheeler, M. B., Gelling, R. W., Brown, J. C., & Pederson, R. A. (1996) · Acta Physiologica Scandinavica · doi:10.1046/j.1365-201x.1996.44267000.x · Cited by 26
Self-citationGan, J., Alonso-Gómez, A. L., Avendano, G., Johnson, B., & Iuvone, P. M. (1995) · Neurochemistry International · doi:10.1016/0197-0186(95)00035-7 · Cited by 21 · cited 1×
“This includes myocardial function (31), glucoseinduced insulin biosynthesis (32), and induction of retinal N-acetyltransferase activity (33).”
BackgroundMetabolic Effects of Gastric Inhibitory Polypeptide
Ebert, R., & Creutzfeldt, W. (2015) · Frontiers of hormone research · doi:10.1159/000414308 · Cited by 11 · cited 3×
“In contrast, Ebert and Creutzfeldt (15), using a similar adipocyte preparation, found that GIP stimulated cAMP production and induced small increases in glycerol release.”
BackgroundSecretion of Gastric Inhibitory Polypeptide in Patients with Bile Duct Obstruction
Yoshidome, K., Miyata, M., Izukura, M., Mizutani, S., Sakamoto, T., Tominaga, H., & Matsuda, H. (1995) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529509089794 · Cited by 7 · cited 1×
“Ingestion of triglycerides increases circulating GIP by a pathway that involves both metabolism (6, 7) and absorption of fatty acids (8, 9).”
BackgroundControl of Insulin Biosynthesis in the Human Fetal Beta Cell
Simpson, A. M., & Tuch, B. E. (1995) · Pancreas · doi:10.1097/00006676-199507000-00005 · Cited by 7 · cited 1×
“This includes myocardial function (31), glucoseinduced insulin biosynthesis (32), and induction of retinal N-acetyltransferase activity (33).”
Background
Research works printed but not linked: 3
- Wieland, 1974, Glycerol U.V. method. In: Burgmeyer HU (ed) Methods of Enzymatic Analysis., Academic Press, New York, vol, 4, 1404
- Flakoll, 1996, Physiologic action of insulin., 121
- Geahlen, 1990, Protein-tyrosine kinases, 239
Cited by
Molecular Mechanisms Regulating Hormone-Sensitive Lipase and Lipolysis
Holm, C., Østerlund, T., Laurell, H., & Contreras, J. A. (2000) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.20.1.365 · Cited by 564
International Union of Pharmacology. XXXV. The Glucagon Receptor Family
Mayo, K. E., Miller, L. J., Bataille, D., Dalle, S., Göke, B., Thorens, B., & Drucker, D. J. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.1.6 · Cited by 506
Green, B. D., Flatt, P. R., & Bailey, C. J. (2006) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2006.024 · Cited by 223
Activation of Lipoprotein Lipase by Glucose-dependent Insulinotropic Polypeptide in Adipocytes
Kim, S.-J., Nian, C., & McIntosh, C. H. S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609088200 · Cited by 216
Self-citationAsmar, M., Simonsen, L., Madsbad, S., Stallknecht, B., Holst, J. J., & Bülow, J. (2010) · Diabetes · doi:10.2337/db10-0098 · Cited by 184
“In vitro studies have shown that GIP stimulates lipolysis (16,17).”
Background
Metadata
- Authors
- McIntosh, C. H. S., Bremsak, I., Lynn, F. C., Gill, R., Hinke, S. A., Gelling, R., Nian, C., McKnight, G., Jaspers, S., & Pederson, R. A.
- Affiliations
- University of British Columbia (CA)
- Department of Zymogenetics, Inc. (G.M., S.J.), Seattle, Washington
- Corresponding author
- McIntosh, Christopher H. S.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 1999-01-01
- Volume
- 140
- Issue
- 1
- Pages
- 398-404
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2001123714
- Cited by
- 73
- References
- 49
- Citations by year
- 2026: 6 · 2025: 4 · 2024: 5 · 2023: 1 · 2022: 1 · 2021: 2 · 2020: 3 · 2019: 6 · 2018: 1 · 2015: 1 · 2014: 1 · 2012: 7
- FWCI
- 0.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Canadian Diabetes Association
- Medical Research Council Canada
- Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- glucose-dependent insulinotropic polypeptide, lipolysis, adipocytes, 3T3-L1 cells, GIP receptor, insulin antagonism, wortmannin, phosphatidylinositol 3-kinase, cAMP signaling, glycerol release, fat metabolism
- MeSH terms
- Adenylyl Cyclase Inhibitors, Wortmannin, Cyclic AMP, Androstadienes, Animals, Cell Differentiation, Gastric Inhibitory Polypeptide, Insulin, Insulin Antagonists, Lipolysis, Receptors, Gastrointestinal Hormone, RNA, Messenger, 3T3 Cells, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.